2019 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021. - Report compiled based on decisions received by WADA before 31 January 2021

• The Report highlights 1,914 confirmed Anti-Doping Rule Violations in 2019, involving individuals from 117 nationalities and across 89 sports
• 1,537 ADRVs came from Adverse Analytical Findings and 377 from non-analytical, evidence-based intelligence

The World Anti-Doping Agency (WADA) has published its seventh annual Anti-Doping Rule Violations (ADRVs) Report, which is the official set of such figures under the World Anti-Doping Code. As usual, the Report is available in a PDF version as well as a dynamic, Excel version that illustrates the ADRV results in an interactive fashion.

The Report illustrates doping offences committed in global sport during 2019. It includes all decisions received by WADA’s Legal Affairs Department up to 31 January 2021. It highlights that there were a total of 1,914 ADRVs recorded in 2019. This represents a slight decrease relative to the 2018 figure of 1,923.

1,537 of the ADRVs came out of Adverse Analytical Findings (AAFs), commonly known as ‘positive’ results. The remainder were derived from investigations and evidence-based intelligence into 377 violations committed by athletes and athlete support personnel.

The 2019 Anti-Doping Rule Violations Report contains all ADRV decisions reported to WADA by Anti-Doping Organizations (ADOs). These decisions include those from AAFs reported in samples collected by ADOs in 2019 as well as from non-analytical ADRV decisions rendered in 2019.

As with previous years, the beginning of the report comprises explanations and definitions, an introduction and an executive summary highlighting key data. The first and second sections present the Results Management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected in 2019 from athletes in- and out-of-competition. They are presented by sport category (Section 1) and testing authority category (Section 2).

Section 3 includes ADRVs that resulted from non-analytical findings committed by athletes (presented by sport and nationality) and by athlete support personnel (presented by nationality).

Section 4 indicates the total number of ADRVs in 2019, which includes AAFs that resulted in an ADRV plus all non-analytical ADRVs. It presents the data by sport and nationality and is further broken down into type of samples (urine or blood), type of test (in- or out-of-competition) and athlete sex classification.
 

2019 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020

Contents:

• Executive Summary - pp. 2-8 (7 pages)
• Laboratory Report -– pp. 9-37 (28 pages)
• Sport Report - pp. 38-174 (137 pages)
• Testing Authority Report - pp. 175-313 (139 pages)
• ABP Report-Blood Analysis - pp. 314-355 (42 pages)

Report Highlights

• A 5.5% increase in the overall number of samples analyzed: 263,519 in 2018 to 278,047 in 2019.
• A slight decrease in the total percentage of Adverse Analytical Findings (AAFs): 1.05% in 2018 (2,774 AAFs from 263,519 samples) to 0.97% in 2019 (2,702 AAFs from 278,047 samples).
• About 60% of WADA-accredited Laboratories saw an increase in the total number of samples recorded.
• An almost similar total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.3% in 2018 (24,495 of 263,519) and 9.1% in 2019 (25,339 of 278,047).
• An increase of 16% in the number of ABP blood samples tested: 31,265 in 2018 to 36,401 in 2019.
• An increase in AAFs reported for Erythropoiesis Stimulating Agents (ESAs), Growth Hormone (GH) and Growth Hormone Releasing Factors (GHRFs).

The World Anti-Doping Agency (WADA) has published its 2019 Testing Figures Report (2019 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2019.

This is the fifth set of global testing figures under the version of the World Anti-Doping Code (Code) that came into effect in January 2015. The 2019 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting AAFs and Atypical Findings (ATFs).

2020 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021

Contents:

• Executive Summary - pp. 2-9 (7 pages)
• Laboratory Report -– pp. 10-36 (27 pages)
• Sport Report - pp. 37-137 (101 pages)
• Testing Authority Report - pp. 138-244 (107 pages)
• ABP Report-Blood Analysis - pp. 245-279 (35 pages)

Report Highlights:

• A 46% decrease in the overall number of samples analyzed: 278,047 in 2019 to 149,758 in 2020.
• A decrease in the total percentage of Adverse Analytical Findings (AAFs): 0.97% in 2019 (2,702 AAFs from 278,047 samples) to 0.67% in 2020 (1,009 AAFs from 149,758 samples).
• All WADA-accredited Laboratories saw a decrease in the total number of samples recorded.
• A decrease in the total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.1% in 2019 (25,339 of 278,047) and 7.3% (10,940 of 149,758) in 2020.
• A decrease of 38% in the number of ABP blood samples tested: 36,401 in 2019 to 22,666 in 2020.

The World Anti-Doping Agency (WADA) has publishes its 2020 Testing Figures Report (2020 Report), which summarizes the results of all the samples WADA-accredited Laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2020.

This is the sixth and last set of global testing figures under the 2015 World Anti-Doping Code (Code) that came into effect in January 2015. The 2020 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples; blood and ABP blood data; and, the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).

2021 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2023

Contents:

• Executive Summary - pp. 2-9 (7 pages)
• Laboratory Report -– pp. 10-39 (30 pages)
• Sport Report - pp. 40-153 (114 pages)
• Testing Authority Report - pp. 154-267 (114 pages)
• ABP Report-Blood Analysis - pp. 268-311 (44 pages)

Report Highlights:

• A 61.2% increase in the number of samples (both urine and non-ABP blood samples) analyzed
  and reported into ADAMS: 149,758 in 2020 to 241,430 in 2021.
• An increase in the total number of samples analyzed and reported by nearly all WADAaccredited
  laboratories and WADA-approved laboratories into ADAMS in 2021 compared to 2020.
• An increase in the total number and percentage of non-ABP blood samples analyzed: 7.3%
  (10,940 of 149,758 samples) in 2020 to 9.3% (22,398 Blood + DBS samples out of 241,430).
• An increase of 36% in the number of ABP blood samples analyzed: 22,666 in 2020 to 30,821
  in 2021.
• A decrease in the total percentage of AAFs: 0.67% in 2020 (1,009 AAFs from 149,758
  samples) to 0.65% (1,560 AAFs from 241,430 samples).
• An increase in the total number of AAFs for growth hormone (GH): 1 in 2020 to 7 in 2021,
  including the first reported AAF for a GH biomarker.
• A 46% decrease in the overall number of samples analyzed: 278,047 in 2019 to 149,758 in 2020.
• A decrease in the total percentage of Adverse Analytical Findings (AAFs): 0.97% in 2019 (2,702 AAFs from 278,047 samples) to 0.67% in 2020 (1,009 AAFs from 149,758 samples).
• All WADA-accredited Laboratories saw a decrease in the total number of samples recorded.
• A decrease in the total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.1% in 2019 (25,339 of 278,047) and 7.3% (10,940 of 149,758) in 2020.
• A decrease of 38% in the number of ABP blood samples tested: 36,401 in 2019 to 22,666 in 2020.

The World Anti-Doping Agency (WADA) has publishes its 2021 Testing Figures Report (2021 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2021.

This is the first set of global testing figures under the 2021 World Anti-Doping Code (Code) that came into effect in January 2021. The 2021 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).

2021 World Anti-Doping Code and International Standard Framework Development and Implementation Guide for Stakeholders / World Anti-Doping Agency (WADA). - Montreal : WADA, 2019

Contents:

1. History of the World Anti-Doping Program
2. 2021 World Anti-Doping Code (Code) Review Process
3. Significant changes between the current 2015 Code and the proposed 2021 Code
4. Significant changes between the current International Standards and the proposed Standards
5. Summary of key topics being addressed in the new Standards
6. Practical steps to be taken by all Code Signatories following the adoption of the 2021 Code
7. General considerations on Code Compliance
8. 2021 Code Stakeholder Support Program
9. Contact information

On 18 October, WADA published a Development and Implementation Guide for Stakeholders, which summarizes matters of importance related to the Review Process; in particular:
- the significant changes between the current 2015 Code and the 2021 Code;
- the significant changes between the current Standards and the recently approved Standards; and
- a summary of the key topics being addressed in the new Standards.

The Guide also touches upon WADA’s Stakeholder Support Program, which WADA will develop and coordinate with partners in 2020. Our aim is to assist Signatories in their adjustment to, and implementation of, the Code and the Standards that will enter into force on 1 January 2021.

2022 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2024

Contents:

• Executive Summary - pp. 2-9 (7 pages)
• Laboratory Report - pp. 10-39 (30 pages)
• Sport Report - pp. 40-155 (116 pages)
• Testing Authority Report - pp. 156-279 (124 pages)
• ABP Report-Blood Analysis - pp. 280-320 (41 pages)

Report Highlights:

• A 6.4% increase in the total number of samples (including urine, non-ABP blood and dried blood spot samples) analyzed and reported into ADAMS in 2022 (256,770) vs. 2021 (241,430); 

• An increase in the total percentage of AAFs year on year; 

• An increase in the total number of samples analyzed and reported by most WADA-accredited laboratories and WADA-approved laboratories into ADAMS in 2022 vs 2021. 

• An increase in the total number and percentage of non-ABP blood and DBS samples analyzed in 2022.  

• An increase of 1.4% in the number of ABP blood samples analyzed in 2022. 

• An increase in the total number of AAFs and % AAF for ERAs [including erythropoietin (EPO) and other EPO-receptor agonists], GHRFs and GC/C/IRMS tests in 2022.  

The World Anti-Doping Agency (WADA) has published its 2022 Testing Figures Report (2022 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2022. 

The 2022 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs). 

A summary of WADA investigations into the International Weightlifting Federation and the sport of weightlifting / Intelligence and Investigations Department. - Montreal : World Anti-Doping Agency (WADA), 2020

• WADA published provisional outcomes of its ongoing investigation into weightlifting
• Inquiry into practice of real-time urine substitution by athletes and the use of ‘doppelgängers’ has uncovered suspected cases involving 18 weightlifters from six countries
• Call for additional powers for WADA’s independent Intelligence and Investigations Department

The World Anti-Doping Agency (WADA) has developed a new method of detecting the prohibited practice of urine substitution at the point of collection and the use of sample surrogates or ‘doppelgängers’, following a ground-breaking investigation into the sport of weightlifting.

After more than three years examining the activities of the International Weightlifting Federation (IWF) and the sport as a whole, WADA’s independent Intelligence and Investigations (I&I) Department today publishes the provisional findings of what is still an ongoing investigation.

Launched in August 2017, WADA I&I’s investigation into weightlifting has four pillars, namely:

1. Operation Outreach, looking into claims that a high-ranking member of the IWF was paid to promote Russian interests and to protect Russian athletes from detection;
2. Operation Heir, investigating allegations of an organized doping and protection scheme operating within Romanian weightlifting;
3. Operation Extra, dealing with the complex process of collection, collation and assessment of all weightlifting intelligence received by WADA I&I; and
4. Operation Arrow, a covert investigation into the practice of urine substitution at the point of collection.

This investigation has focused not just on athletes but also on others who might have been involved in facilitating this deception, including doping control officers, coaches, other athlete support personnel and officials. In 2019, WADA I&I successfully sought the support of multiple law enforcement agencies to investigate some of the allegations mentioned in the report. These law enforcement agencies approved today’s publication of this provisional report.

As it relates to Operation Arrow, the new methodology to refine the identification of potential substitute urine was developed by WADA I&I with assistance in part from confidential sources and analysis experts. This methodology has so far allowed investigators to identify, through DNA profile analysis, cases of suspected urine substitution involving 18 weightlifters from six countries. These cases will be presented to the International Testing Agency (ITA), to which the IWF has now delegated the conduct of its anti-doping program, for results management. WADA I&I found evidence of ‘doppelgängers’ being used to impersonate athletes during the sample collection process, ensuring clean urine was fraudulently provided.

Contents:

1. The Investigations
2. Whistleblowing Program
3. Confidential Information Unit
4. Operation Outreach
5. Operation Heir
6. Operation Extra
7. Operation Arrow
8. Conclusion

An Open Letter on Russian Anti-Doping Compliance from Sir Craig Reedie, President of the World Anti-Doping Agency / Craig Reedie. - Montreal : World Anti-Doping Agency (WADA), 2018

Athlete Vulnerabilities Research Project : descriptive report on sport stakeholders' beliefs about athlete doping vulnerabilities and realted factors / Samuel St-Martin, David Pavot. - Montreal : World Anti-Doping Agency (WADA), 2022

The aim of the survey, conducted in collaboration with Canada’s Université de Sherbrooke Research Chair on Anti-Doping in Sport, was to gather insight from those engaged in sport as to the types of athletes who may be more vulnerable to doping and the factors that contribute to causing vulnerability; and, as a result, to allow International Federations (IFs) and National Federations (NFs) to be more proactive in their protection of vulnerable athletes. The results will also help WADA identify specific areas for further investigation and research.

Nine vulnerability factors were identified as ‘most important’ by both athletes and sport personnel, highlighting the need for education programs that cover a broad range of topics and provide support to athletes through varied means.

Nutritional supplements were considered the leading area of concern by most sport personnel, while athletes pointed to the physical demands of sport and the need for quick physical development and performance improvements.

International-level male athletes were identified as being most vulnerable to intentional doping and inadvertent doping.

Coaches were deemed to be the most influential personnel along the athlete pathway, particularly at the elite levels, an indication of the need for education programs for coaches that provide them with accurate, up-to-date information and advice they can pass along to their athletes. In addition, this highlights that coaches may be best placed to identify vulnerable athletes and be able to intervene, if given the tools and strategies to do so.

Education was considered the most effective way to support athletes who may be vulnerable to doping, along with support beyond traditional education programs, such as nutritional and psychological support.

Athletes must show caution due to contaminated meat / World Anti-Doping Agency (WADA). - Montreal : WADA, 2011

Athletes must show caution due to contaminated meat.

Due to continuing concerns over contaminated meat in certain parts of the world, the World Anti-Doping Agency (WADA) has re-emphasized the need for athletes to exercise extreme caution with regards to eating meat when traveling to competitions in China and Mexico.

It has been shown that Mexico and China have a serious problem with meat contaminated with the prohibited substance clenbuterol, and WADA’s message to athletes competing in these countries remains the same: eat only in restaurants and cafeterias that have been approved by your federation and/or event organizer.

Furthermore, when eating outside these designated cafeteria and restaurants, always try to eat in large numbers.

“We have collected sufficient evidence to demonstrate that in some countries there is a risk of eating meat that might be contaminated so we say to athletes that they should be sensible and cautious about where they eat,” said WADA Director General David Howman.
“At the World Swimming Championships in Shanghai earlier this year, and the recent Pan American Games in Mexico, the advice from WADA was to stick to places given the all clear by event organizers. The Governments were able to give assurances to athletes at those events.
“It is the responsibility of event organizers and governments to ensure the meat available to athletes is not contaminated.
“WADA continues to give the same advice. These countries have assured WADA that they are taking steps to deal with this problem and to enforce laws that are in place to prevent steroid feeding of animals, but at the moment it is vital that athletes, coaches and team managers are aware of ways to avoid any risk.
“It is also important that those sports and organizations who are staging events in these two countries obtain guarantees from the hosting body and government that the food made available to athletes is not contaminated.”

WADA will approach and study any positive case involving clenbuterol on an individual basis.